Combined treatment of IL-1α and TNF-α potentiates the antitumour effect of hyperthermia

International Journal of Hyperthermia

Volumn 12, Issue 3, 1996, Pages 335-344

  Lin, J C ^a   Park, H J ^a   Song, C W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Blood flow; Growth delay; Hyperthermia; IL 1 ; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 1ALPHA; RUBIDIUM 86; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER GRAFT; CLONOGENESIS; CONTROLLED STUDY; DRUG POTENTIATION; HOMEOSTASIS; HYPERTHERMIC THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; TUMOR BLOOD FLOW;

EID: 0029936902     PISSN: 02656736     EISSN: None     Source Type: Journal    
DOI: 10.3109/02656739609022522     Document Type: Article

References (31)

1. AVEBROOK, B. J., YAMAMOTO, R. S., ULICH, T. R., JEFFES, E. W. B., MASUNAK, I., and GRANGER, G. A., 1987, Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin. Journal of Clinical Immunology, 7, 333-340.
2. BABBS, C. F., DEWITT, D. P., VOORHEES, W. D., MCCAW, J. S., and CHAN, P. C., 1982, Theoretical feasibility of vasodilator enhanced local tumor heating. European Journal of Cancer and Clinical Oncology, 18, 1137-1146.
3. BALKWILL, F. R., 1989, Tumor necrosis factor. British Medical Bulletin, 45, 389-400.
4. BELARDELL, F., PROIETTI, E., CIOLLI, V., SESTILI, P., CARPETILLI, G., DI VITO, M., FERRETTI, A., WOODROW, D., BORASCHI, D., and PODIO, F., 1989, Interleukin 1β induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor α and β. International Journal of Cancer, 44, 117-123.
5. BRAUNSCHWEIGER, P. G., JOHNSON, C. S., KUMA, N., ORD, V., and FURMANSKI, P., 1988, Antitumor effects of recombinant human Interleukin 1 in RIF-1 and PancO2 solid tumors. Cancer Research, 48, 6011-6016.
6. BRAUNSCHWEIGER, P. G., JOHNSON, C. S., KUMAR, N., ORD, V., and FURMANSKI, P., 1990a. The effect of adrenalectomy and dexamethasone on interleukin-1α induced responses in RIF-1 tumors. British Journal of Cancer, 61, 9-13.
7. BRAUNSCHWEIGER, P. G., KUMAR, N., CONASTANTINIDIS, I., WEHRLE, J. P., GLICKSON, J. D., JOHNSON, C. S., and FURMANSKI, P., 1990b. Potentiation of interleukin 1α-mediated antitumor effects by ketoconazole. Cancer Research. 50, 4709-4717.
8. BUTLER, L. D., LAYMAN, N. K., CAIN, R. L., RIEDL, P. E., MOHLER, K. M., BOBBITT, J. L., BELAGAJIE, R., SHARP, J., and BENDELE, A. M., 1989, Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacological intervention. Clinical Immunology and Immunopathology, 53, 400-421.
9. CLAUSS, M., GERLACH, M., GERLACH, H., BRETT, J., WANG, F., FAMILLETTI, P. C., PAN, Y. C. E., OLANDER, J. V., CONNOLLY, D. T., and STERN, D., 1990, Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cells and monocyte procoagulant activity, and promotes monocyte migration. Journal of Experimental Medicine, 172, 1535-1545.
10. 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin-1α on the bioenergetics of RIF-1 tumors. Cancer Research, 49, 6379-6382.
11. HORSMAN, M. R., CHRISTINSEN, K. L., and OVERGAARD, J., 1989, Hydralazine-induced enhancement of hyperthermia damage in a C3H mammary carcinoma in vivo. International Journal of Hyperthermia, 5, 123-136.
12. JAIN, R. K., SHAH, S. A., and FINNEY, P. L., 1984, Continuous noninvasive monitoring of pH and temperature in rat Walker 256 carcinoma during normoglycemia and hyperglycemia. Journal of the National Cancer Institute, 73, 429-436.
13. JAIN, R. K., and WARD-HARTLEY, K., 1984, Tumor blood flow: characterization, modifications and role in hyperthermia. IEEE Transactions, Sonics Ultrasonics SU-31, 504-526.
14. JOHNSON, C. W., CHANG, M. J., BRAUNSCHWEIGER, P. G., and FURNANSKI, P., 1991, Acute hemorrhagic necrosis of tumors induced by interkeukin-1 a: effects independent of tumor necrosis factor. Journal of the National Cancer Institute, 83, 842-848.
15. KALLINOWSKI, F., SCHAEFER, C., TYLER, G., and VAUPEL, P., 1989, In vivo targets of recombinant human tumor necrosis factor-α: blood flow, oxygen consumption and growth of isotransplanted rat tumors. British Journal of Cancer, 60, 555-560.
16. KLUGE, M., ELGER, B., ENGEL, T., SCHAEFER, C., SEEGA, J., and VAUPEL, P., 1992, Acute effects of tumor necrosis factor α or lymphotoxin on global blood flow, laser Doppler flux, and bioenergetic status of subcutaneous rodent tumors. Cancer Research, 52, 2167-2173.
17. LIN, J. C., and SONG, C. W., 1990, Effects of hydralazine on the blood flow in RIF-1 tumors and normal tissues of mice. Radiation Research, 124, 171-177.
18. MAIER, J. A. M., STATUTO, M., and RAGNOTTI, G., 1994, Endogenous interleukin-1α must be transported to the nucleus to exert its activity in human endothelial cells. Molecular and Cellular Biology, 14, 1845-1851.
19. MANDA, T., SHIMONURA, K., MUKUMOTO, S., KOBAYASHI, K., MIZOTA, T., HIRAI, O., MATSUMOTO, S., OKU, T., NISHIGAKI, F., MORI, J., and KIKUCHI, H., 1987, Recombinant human tumor necrosis factor-α: evidence of indirect mode of antitumor activity. Cancer Research, 47, 3703-3711.
20. MANTOVANI, A., BUSSOLINO, F., and DEIANA, E., 1992, Cytokine regulation of endothelial cell function. FASEB Journal, 6, 2591-2599.
21. MOVAT, H. Z., 1987, Tumor necrosis factor and interleukin 1: role in acute inflammation and microvascular injury. Journal of Laboratory and Clinical Medicine, 110, 668-681.
22. POBER, J., and COTRAN, R. S., 1990, Cytokines and endothelial cell biology. Physiology Review, 70, 427-451.
23. REINHOLD, H. S., and ENDRICH, B., 1986, Tumor microcirculation as a target for hyperthermia. International Journal of Hyperthermia, 2, 111-137.
24. SONG, C. W., 1984, Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Research, 44, 4721s-4730s.
25. SONG, C. W., KANG, M. S., RHEE, J. G., and LEVITT, S. H., 1980, Vascular damage and delayed cell death in tumors after hyperthermia. British Journal of Cancer, 41, 309-312.
26. SONG, C. W., LIN, J. C., and LYONS, J. C., 1993, Antitumour effect of interleukin-1α in combination with hyperthermia. Cancer Research, 53, 324-328.
27. TOMASOVIC, S. P., LU, S., and KLOSTERGAARD, J., 1992, Comparative In vivo studies of the potentiation of tumor necrosis factor (TNF)-α. TNF-3, and TNF-SAM2 cytotoxicity by hyperthermia. Journal of Immunotherapy, 11, 85-92.
28. URANO, M., MANTOYA, V., and BOOTH, A., 1983, Effect of hyperglycemia on the thermal response of murine normal and tumor tissues. Cancer Research, 43, 453-455.
29. VAUPEL, P., KALLINOWSKI, F., and KLUGE, M., 1988. Pathophysiology of tumors in hyperthermia. Recent Result Cancer Research, 107, 65-75.
30. VON ARDENNE, M., 1972, Selective multiphase cancer therapy. Conceptual aspects and experimental basis. Advanced Pharmacology and Chemotherapy, 10, 339-380.
31. WATANABE, N., NIITSU, Y., UMENO, H., KURIYAMA, H., NEDA, H., YAMAKUCHI, N., MAEDA, M., and URUSHIZAKI, I., 1988, Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Research, 48, 2179-2183.